Form 4 for SKIN SkinHealth Systems Inc.
Accepted 2022-02-09 00:00:00 ET · period of report 2022-02-07 · accession 0001818093-22-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-09 | 2022-02-07 | SKIN | Stanleick Andrew Roy | CEO, Dir | A - Grant | — | +333.3K | 333.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-07 | A | A | 333,333 | — | 333,333 | D | — | — | (F1) Represents a grant of restricted stock units ("RSUs"); 12.5% of the RSUs will vest on the six-month anniversary of the Vesting Commencement Date of February 4, 2022, 12.5% of the RSUs will vest on the first anniversary of such Vesting Commencement Date, and 25% of the RSUs will vest on each of the second, third and fourth anniversaries of such Vesting Commencement Date, in each case subject to continued service through the vesting date and certain acceleration rights. |